# FDA recall D-0205-2024

> **Legacy Pharmaceutical Packaging LLC** · Class II · drug recall initiated 2023-12-11.

## Product

Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54

## Reason for recall

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

## Distribution

CA and AR

## Key facts

- **Recall number:** D-0205-2024
- **Recalling firm:** Legacy Pharmaceutical Packaging LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-12-11
- **Report date:** 2024-01-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Earth City, MO, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0205-2024

## Citation

> AI Analytics. FDA recall D-0205-2024. Retrieved 2026-07-10 from https://api.ai-analytics.org/recall/D-0205-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*